Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 03 2023
Historique:
received: 06 09 2022
accepted: 06 03 2023
entrez: 8 3 2023
pubmed: 9 3 2023
medline: 11 3 2023
Statut: epublish

Résumé

Determining whether SARS-CoV-2 exhibits seasonality like other respiratory viruses is critical for public health planning. We evaluated whether COVID-19 rates follow a seasonal pattern using time series models. We used time series decomposition to extract the annual seasonal component of COVID-19 case, hospitalization, and mortality rates from March 2020 through December 2022 for the United States and Europe. Models were adjusted for a country-specific stringency index to account for confounding by various interventions. Despite year-round disease activity, we identified seasonal spikes in COVID-19 from approximately November through April for all outcomes and in all countries. Our results support employing annual preventative measures against SARS-CoV-2, such as administering seasonal booster vaccines in a similar timeframe as those in place for influenza. Whether certain high-risk individuals may need more than one COVID-19 vaccine booster dose each year will depend on factors like vaccine durability against severe illness and levels of year-round disease activity.

Identifiants

pubmed: 36890264
doi: 10.1038/s41598-023-31057-1
pii: 10.1038/s41598-023-31057-1
pmc: PMC9994397
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3886

Informations de copyright

© 2023. The Author(s).

Références

J Virol. 2014 Jul;88(14):7692-5
pubmed: 24789791
Environ Res. 2021 Apr;195:110874
pubmed: 33610582
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33380411
Nat Hum Behav. 2021 Apr;5(4):529-538
pubmed: 33686204
JAMA Netw Open. 2021 Sep 1;4(9):e2124650
pubmed: 34529066
Annu Rev Virol. 2020 Sep 29;7(1):83-101
pubmed: 32196426
Lancet Respir Med. 2022 Jul;10(7):e61-e62
pubmed: 35533699
mSphere. 2020 Jul 1;5(4):
pubmed: 32611701
Nature. 2022 Aug;608(7923):603-608
pubmed: 35790190
Geohealth. 2021 Jun 01;5(6):e2021GH000413
pubmed: 34095688
Influenza Other Respir Viruses. 2020 Nov;14(6):638-646
pubmed: 32163226
Lancet Reg Health Am. 2022 May;9:100198
pubmed: 35187521
J Virol. 2007 Jun;81(11):5429-36
pubmed: 17182688
Nature. 2022 Feb;602(7897):487-495
pubmed: 34942634
BMC Infect Dis. 2021 Oct 26;21(1):1101
pubmed: 34702177
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145
pubmed: 35085224
BMC Public Health. 2022 Sep 17;22(1):1765
pubmed: 36115936
Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27456-27464
pubmed: 33051302
N Engl J Med. 2022 May 5;386(18):1712-1720
pubmed: 35381126
MMWR Recomm Rep. 2021 Aug 27;70(5):1-28
pubmed: 34448800
MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):255-263
pubmed: 35176007
MMWR Morb Mortal Wkly Rep. 2022 Apr 01;71(13):489-494
pubmed: 35358168

Auteurs

Timothy L Wiemken (TL)

Pfizer Inc., 500 Arcola Rd., Collegeville, PA, 19426, USA. timothy.wiemken@pfizer.com.

Farid Khan (F)

Pfizer Inc., 500 Arcola Rd., Collegeville, PA, 19426, USA.

Laura Puzniak (L)

Pfizer Inc., 500 Arcola Rd., Collegeville, PA, 19426, USA.

Wan Yang (W)

Columbia University Mailman School of Public Health-Epidemiology, 722 West 168th St., New York, NY, 10032, USA.

Jacob Simmering (J)

Department of Internal Medicine-Pulmonary, Critical Care, and Occupational Medicine, University of Iowa, Iowa City, IA, 52242, USA.

Philip Polgreen (P)

Department of Internal Medicine-Infectious Diseases, University of Iowa, Iowa City, IA, 52242, USA.

Jennifer L Nguyen (JL)

Pfizer Inc., 500 Arcola Rd., Collegeville, PA, 19426, USA.

Luis Jodar (L)

Pfizer Inc., 500 Arcola Rd., Collegeville, PA, 19426, USA.

John M McLaughlin (JM)

Pfizer Inc., 500 Arcola Rd., Collegeville, PA, 19426, USA. john.mclaughlin@pfizer.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH